Interferon Beta-1A: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Interferon Beta-1A. Educational only — not medical advice.
Labeled uses
AVONEX is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
Source: FDA labeling via NIH DailyMed (set d70a39cc…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.